Treatment Response and Tolerability of Pegylated Interferon-Α Plus Ribavirin Combination Therapy in Elderly Patients (≥ 65 Years) With Chronic Hepatitis C in Korea
Hepatitis Monthly - Netherlands
doi 10.5812/hepatmon.6170
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2012
Authors
Publisher
Kowsar Medical Institute